Canadian Cancer Trials Group
Clinical trials sponsored by Canadian Cancer Trials Group, explained in plain language.
-
Prostate cancer radiation showdown: which treatment wins?
Disease control CompletedThis study compared two types of radiation therapy for men with intermediate-risk prostate cancer: standard image-guided external beam radiation (IGRT) versus IGRT plus a high-dose-rate brachytherapy boost. The goal was to see which treatment works better and what side effects oc…
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
Breast cancer study tests smarter dosing for better results
Disease control CompletedThis study looked at 180 women with a certain type of advanced breast cancer (ER positive, HER2 negative). It compared two different schedules of the drug palbociclib combined with hormone therapy to see which one worked better and caused fewer treatment delays. The goal was to f…
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug combo shows promise for advanced cancers
Disease control CompletedThis study tested a new drug called RP-6306 in 28 people with advanced cancer that could not be cured. The goal was to see if adding RP-6306 to standard treatment is safe and works better than standard care alone. Researchers also checked if certain biomarkers in patients helped …
Phase: PHASE2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated May 01, 2026 15:56 UTC
-
Exercise after colon cancer: does it keep the disease away?
Disease control CompletedThis study looked at whether a structured physical activity program, along with health education, could help prevent colon cancer from returning in people who had surgery and chemotherapy for high-risk stage II or stage III colon cancer. A total of 889 patients took part. The mai…
Phase: NA • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC
-
Could a simple shot protect cancer patients from severe COVID-19?
Prevention CompletedThis study tested whether a treatment called IMM-101 could help prevent severe respiratory infections, including COVID-19, in cancer patients who are at higher risk. About 195 people with cancer who were receiving active treatment took part. Half received IMM-101 and the other ha…
Phase: PHASE3 • Sponsor: Canadian Cancer Trials Group • Aim: Prevention
Last updated Apr 29, 2026 15:15 UTC